Superworth

Cosmos Health EPS COSM

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.61
Latest quarter, Q2 FY26
−$0.10
Fiscal year 2025
−$0.58

Cosmos Health's earnings per share was −$0.61 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.10.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.58n/a
FY2024−$1.12n/a
FY2023−$1.92n/a
FY2022−$45.26n/a
FY2021−$23.00−1633%
FY2020$1.50n/a
FY2019−$6.25n/a
FY2018−$17.00n/a
FY2017−$12.25n/a
FY2016$0.00n/a
FY2015−$12.50−200%
FY2014$12.50n/a
FY2013n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.10n/a−$0.61
Q1 FY26−$0.06n/a−$0.61
Q4 FY25−$0.28n/a−$0.58
Q3 FY25−$0.17n/a−$0.71
Q2 FY25−$0.10n/a−$0.99
Q1 FY25−$0.03n/a−$1.04
Q4 FY24−$0.41n/a−$1.12
Q3 FY24−$0.45n/a−$2.23
Q2 FY24−$0.15n/a−$2.05
Q1 FY24−$0.11n/a−$1.99
Q4 FY23−$1.52n/a−$1.92
Q3 FY23−$0.27n/a−$12.50

Against its peers

Companies in Healthcare nearest Cosmos Health's size, closest first, today.

CompanyEPS, 12 monthsGrowth
COSMCosmos Health−$0.61
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ICCCImmucell$0.08−58% a year
KEQUKewaunee Scientific$2.76−33% a year
PDEXPro DEX$4.11+52% a year
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Cosmos Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.